Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $506.89 | 16 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $306.98 | 3 | $0 (2019) |
| AbbVie Inc. | $119.23 | 8 | $0 (2021) |
| Olympus America Inc. | $62.38 | 4 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $18.30 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $50.81 | 3 | AbbVie Inc. ($50.81) |
| 2020 | $18.30 | 1 | Takeda Pharmaceuticals U.S.A., Inc. ($18.30) |
| 2019 | $174.55 | 6 | Boston Scientific Corporation ($96.52) |
| 2018 | $162.80 | 4 | BOSTON SCIENTIFIC CORPORATION ($121.58) |
| 2017 | $100.43 | 2 | BOSTON SCIENTIFIC CORPORATION ($88.88) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/24/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $11.11 | General |
| Category: IMMUNOLOGY | ||||||
| 07/27/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: IMMUNOLOGY | ||||||
| 04/01/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: IMMUNOLOGY | ||||||
| 01/06/2020 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/22/2019 | Olympus America Inc. | Olympus Tissue Acquisition Devices (Device) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: EndoTherapy Products | ||||||
| 08/21/2019 | Olympus America Inc. | Olympus Hemostasis Devices (Device) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: EndoTherapy Products | ||||||
| 08/21/2019 | Olympus America Inc. | Olympus Hemostasis Devices (Device) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: EndoTherapy Products | ||||||
| 08/19/2019 | Olympus America Inc. | Olympus Hemostasis Devices (Device) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: EndoTherapy Products | ||||||
| 04/25/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Immunology | ||||||
| 03/07/2019 | Boston Scientific Corporation | GENERAL BILIARY DEVICES (Device) | Food and Beverage | In-kind items and services | $96.52 | General |
| Category: BILIARY DEVICES | ||||||
| 12/04/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Immunology | ||||||
| 10/11/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $11.04 | General |
| Category: Immunology | ||||||
| 08/15/2018 | BOSTON SCIENTIFIC CORPORATION | GENERAL BILIARY DEVICES (Device) | Food and Beverage | In-kind items and services | $121.58 | General |
| Category: BILIARY DEVICES | ||||||
| 01/17/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: Immunology | ||||||
| 10/18/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $11.55 | General |
| Category: Immunology | ||||||
| 05/24/2017 | BOSTON SCIENTIFIC CORPORATION | SPYGLASS DIRECT VISUALIZATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $88.88 | General |
| Category: BILIARY DEVICES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 19 | 826 | 891 | $299,169 | $96,090 |
| 2020 | 14 | 660 | 723 | $227,906 | $76,720 |
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 197 | 197 | $101,446 | $36,891 | 36.4% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 120 | 124 | $51,514 | $8,854 | 17.2% |
| 43274 | Insertion of stent into pancreatic or bile duct using a flexible endoscope via mouth | Facility | 2021 | 20 | 21 | $9,876 | $7,562 | 76.6% |
| 43264 | Removal of stone or debris from bile or pancreatic duct using a flexible endoscope via mouth | Facility | 2021 | 34 | 38 | $23,763 | $6,818 | 28.7% |
| 45390 | Removal of large bowel tissue using a flexible endoscope (colonoscopy) | Facility | 2021 | 24 | 24 | $10,709 | $6,216 | 58.0% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 57 | 57 | $26,767 | $4,514 | 16.9% |
| 43248 | Insertion of guide wire with dilation of esophagus using an endoscope | Facility | 2021 | 40 | 41 | $18,132 | $4,409 | 24.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 43 | 54 | $4,641 | $3,699 | 79.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 35 | 37 | $4,402 | $3,454 | 78.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2021 | 19 | 19 | $6,550 | $3,416 | 52.2% |
| 43235 | Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 33 | 33 | $10,238 | $2,530 | 24.7% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2021 | 13 | 13 | $3,426 | $2,307 | 67.3% |
| 43262 | Incision of pancreatic outlet using a flexible endoscope via mouth | Facility | 2021 | 27 | 27 | $21,828 | $2,238 | 10.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 11 | 11 | $1,590 | $1,160 | 73.0% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 55 | 55 | $2,312 | $640.85 | 27.7% |
| 76705 | Ultrasound of abdomen, limited | Office | 2021 | 12 | 12 | $776.44 | $562.10 | 72.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 26 | 35 | $558.43 | $369.60 | 66.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 21 | 36 | $442.72 | $279.72 | 63.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 39 | 57 | $197.79 | $171.00 | 86.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope | Facility | 2020 | 154 | 156 | $71,014 | $30,791 | 43.4% |
| 43264 | Removal of stone from bile or pancreatic duct using an endoscope | Facility | 2020 | 37 | 39 | $29,727 | $8,812 | 29.6% |
| 43274 | Placement of stent pancreatic or bile duct using an endoscope | Facility | 2020 | 24 | 24 | $15,943 | $8,792 | 55.1% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 94 | 96 | $34,578 | $6,856 | 19.8% |
| 45380 | Biopsy of large bowel using an endoscope | Facility | 2020 | 54 | 54 | $22,386 | $5,352 | 23.9% |
| 43248 | Insertion of guide wire with dilation of esophagus using an endoscope | Facility | 2020 | 45 | 45 | $16,805 | $5,180 | 30.8% |
About Michael Mcguire
Michael Mcguire is a Gastroenterology healthcare provider based in Rapid City, South Dakota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831138098.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michael Mcguire has received a total of $506.89 in payments from pharmaceutical and medical device companies, with $50.81 received in 2021. These payments were reported across 16 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($506.89).
As a Medicare-enrolled provider, Mcguire has provided services to 1,486 Medicare beneficiaries, totaling 1,614 services with total Medicare billing of $172,810. Data is available for 2 years (2020–2021), covering 33 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Rapid City, SD
- Active Since 06/05/2006
- Last Updated 11/05/2007
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1831138098
Products in Payments
- GENERAL BILIARY DEVICES (Device) $121.58
- GENERAL BILIARY DEVICES (Device) $96.52
- SPYGLASS DIRECT VISUALIZATION SYSTEM (Device) $88.88
- Humira (Biological) $68.42
- HUMIRA (Biological) $50.81
- Olympus Hemostasis Devices (Device) $46.24
- ENTYVIO (Biological) $18.30
- Olympus Tissue Acquisition Devices (Device) $16.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Rapid City
Issam Turk, Md, MD
Gastroenterology — Payments: $6,025
Dr. Oksana Aleksenko, Md, MD
Gastroenterology — Payments: $5,854
Blake Jones, Md, MD
Gastroenterology — Payments: $3,275
Dr. Erik Raborn, Do Mph, DO MPH
Gastroenterology — Payments: $2,298
Dr. Nathan Jaqua, M.d, M.D
Gastroenterology — Payments: $1,821
Gary Bochna
Gastroenterology — Payments: $1,348